Company news
Aethlon Medical, Inc. news in 2020
Aethlon Medical, Inc.'s news releases, calls and decks from 2020, newest first.
Aethlon Medical Announces First Patient Treated in First-in-Human Clinical Trial of HEMOPURIFIER® in Head and Neck Cancer
December 15, 2020
Aethlon Announces Appointment of Charles J. Fisher, Jr., M.D. as Chief Executive Officer
November 2, 2020
Aethlon Medical To Release Second Quarter Financial Results and Host Conference Call on October 28, 2020
October 18, 2020
Aethlon Medical Announces Collaboration with University of Pittsburgh on NIH Grant for Head and Neck Cancer
August 5, 2020
Aethlon Medical To Release First Quarter Financial Results and Host Conference Call on August 11, 2020
August 3, 2020
Aethlon Medical Announces Fiscal Year Financial Results and Provides Corporate Update
June 24, 2020
Aethlon Announces FDA Approval of IDE Supplement for COVID-19 Patients
June 17, 2020
Aethlon Medical To Release Fourth Quarter Financial Results and Host Conference Call on June 25, 2020
June 15, 2020
Aethlon Announces Issuance of European Patent for the Hemopurifier® in Cancer
March 23, 2020
Aethlon Medical Announces Completion of $3.77 Million Registered Direct Offering
January 21, 2020
Aethlon Medical Announces $3.77 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
January 16, 2020